2023-04-012024-03-312024-03-31false12513178ASSURED HEALTH AND PROTECTION LIMITED2024-10-28iso4217:GBPxbrli:pure125131782023-04-01125131782024-03-31125131782023-04-012024-03-31125131782022-04-01125131782023-03-31125131782022-04-012023-03-3112513178bus:SmallEntities2023-04-012024-03-3112513178bus:AuditExempt-NoAccountantsReport2023-04-012024-03-3112513178bus:AbridgedAccounts2023-04-012024-03-3112513178bus:PrivateLimitedCompanyLtd2023-04-012024-03-3112513178core:WithinOneYear2024-03-3112513178core:AfterOneYear2024-03-3112513178core:WithinOneYear2023-03-3112513178core:AfterOneYear2023-03-3112513178core:ShareCapital2024-03-3112513178core:SharePremium2024-03-3112513178core:RevaluationReserve2024-03-3112513178core:OtherReservesSubtotal2024-03-3112513178core:RetainedEarningsAccumulatedLosses2024-03-3112513178core:ShareCapital2023-03-3112513178core:SharePremium2023-03-3112513178core:RevaluationReserve2023-03-3112513178core:OtherReservesSubtotal2023-03-3112513178core:RetainedEarningsAccumulatedLosses2023-03-3112513178core:LandBuildings2024-03-3112513178core:PlantMachinery2024-03-3112513178core:Vehicles2024-03-3112513178core:FurnitureFittings2024-03-3112513178core:OfficeEquipment2024-03-3112513178core:NetGoodwill2024-03-3112513178core:IntangibleAssetsOtherThanGoodwill2024-03-3112513178core:ListedExchangeTraded2024-03-3112513178core:UnlistedNon-exchangeTraded2024-03-3112513178core:LandBuildings2023-03-3112513178core:PlantMachinery2023-03-3112513178core:Vehicles2023-03-3112513178core:FurnitureFittings2023-03-3112513178core:OfficeEquipment2023-03-3112513178core:NetGoodwill2023-03-3112513178core:IntangibleAssetsOtherThanGoodwill2023-03-3112513178core:ListedExchangeTraded2023-03-3112513178core:UnlistedNon-exchangeTraded2023-03-3112513178core:LandBuildings2023-04-012024-03-3112513178core:PlantMachinery2023-04-012024-03-3112513178core:Vehicles2023-04-012024-03-3112513178core:FurnitureFittings2023-04-012024-03-3112513178core:OfficeEquipment2023-04-012024-03-3112513178core:NetGoodwill2023-04-012024-03-3112513178core:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3112513178core:ListedExchangeTraded2023-04-012024-03-3112513178core:UnlistedNon-exchangeTraded2023-04-012024-03-3112513178core:MoreThanFiveYears2023-04-012024-03-3112513178core:Non-currentFinancialInstruments2024-03-3112513178core:Non-currentFinancialInstruments2023-03-3112513178dpl:CostSales2023-04-012024-03-3112513178dpl:DistributionCosts2023-04-012024-03-3112513178core:LandBuildings2023-04-012024-03-3112513178core:PlantMachinery2023-04-012024-03-3112513178core:Vehicles2023-04-012024-03-3112513178core:FurnitureFittings2023-04-012024-03-3112513178core:OfficeEquipment2023-04-012024-03-3112513178dpl:AdministrativeExpenses2023-04-012024-03-3112513178core:NetGoodwill2023-04-012024-03-3112513178core:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3112513178dpl:GroupUndertakings2023-04-012024-03-3112513178dpl:ParticipatingInterests2023-04-012024-03-3112513178dpl:GroupUndertakingscore:ListedExchangeTraded2023-04-012024-03-3112513178core:ListedExchangeTraded2023-04-012024-03-3112513178dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-04-012024-03-3112513178core:UnlistedNon-exchangeTraded2023-04-012024-03-3112513178dpl:CostSales2022-04-012023-03-3112513178dpl:DistributionCosts2022-04-012023-03-3112513178core:LandBuildings2022-04-012023-03-3112513178core:PlantMachinery2022-04-012023-03-3112513178core:Vehicles2022-04-012023-03-3112513178core:FurnitureFittings2022-04-012023-03-3112513178core:OfficeEquipment2022-04-012023-03-3112513178dpl:AdministrativeExpenses2022-04-012023-03-3112513178core:NetGoodwill2022-04-012023-03-3112513178core:IntangibleAssetsOtherThanGoodwill2022-04-012023-03-3112513178dpl:GroupUndertakings2022-04-012023-03-3112513178dpl:ParticipatingInterests2022-04-012023-03-3112513178dpl:GroupUndertakingscore:ListedExchangeTraded2022-04-012023-03-3112513178core:ListedExchangeTraded2022-04-012023-03-3112513178dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-04-012023-03-3112513178core:UnlistedNon-exchangeTraded2022-04-012023-03-3112513178core:NetGoodwill2024-03-3112513178core:IntangibleAssetsOtherThanGoodwill2024-03-3112513178core:LandBuildings2024-03-3112513178core:PlantMachinery2024-03-3112513178core:Vehicles2024-03-3112513178core:FurnitureFittings2024-03-3112513178core:OfficeEquipment2024-03-3112513178core:AfterOneYear2024-03-3112513178core:WithinOneYear2024-03-3112513178core:ListedExchangeTraded2024-03-3112513178core:UnlistedNon-exchangeTraded2024-03-3112513178core:ShareCapital2024-03-3112513178core:SharePremium2024-03-3112513178core:RevaluationReserve2024-03-3112513178core:OtherReservesSubtotal2024-03-3112513178core:RetainedEarningsAccumulatedLosses2024-03-3112513178core:NetGoodwill2023-03-3112513178core:IntangibleAssetsOtherThanGoodwill2023-03-3112513178core:LandBuildings2023-03-3112513178core:PlantMachinery2023-03-3112513178core:Vehicles2023-03-3112513178core:FurnitureFittings2023-03-3112513178core:OfficeEquipment2023-03-3112513178core:AfterOneYear2023-03-3112513178core:WithinOneYear2023-03-3112513178core:ListedExchangeTraded2023-03-3112513178core:UnlistedNon-exchangeTraded2023-03-3112513178core:ShareCapital2023-03-3112513178core:SharePremium2023-03-3112513178core:RevaluationReserve2023-03-3112513178core:OtherReservesSubtotal2023-03-3112513178core:RetainedEarningsAccumulatedLosses2023-03-3112513178core:NetGoodwill2022-04-0112513178core:IntangibleAssetsOtherThanGoodwill2022-04-0112513178core:LandBuildings2022-04-0112513178core:PlantMachinery2022-04-0112513178core:Vehicles2022-04-0112513178core:FurnitureFittings2022-04-0112513178core:OfficeEquipment2022-04-0112513178core:AfterOneYear2022-04-0112513178core:WithinOneYear2022-04-0112513178core:ListedExchangeTraded2022-04-0112513178core:UnlistedNon-exchangeTraded2022-04-0112513178core:ShareCapital2022-04-0112513178core:SharePremium2022-04-0112513178core:RevaluationReserve2022-04-0112513178core:OtherReservesSubtotal2022-04-0112513178core:RetainedEarningsAccumulatedLosses2022-04-0112513178core:AfterOneYear2023-04-012024-03-3112513178core:WithinOneYear2023-04-012024-03-3112513178core:Non-currentFinancialInstrumentscore:CostValuation2023-04-012024-03-3112513178core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-04-012024-03-3112513178core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-04-012024-03-3112513178core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-04-012024-03-3112513178core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-04-012024-03-3112513178core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-04-012024-03-3112513178core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-04-012024-03-3112513178core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-04-012024-03-3112513178core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-04-012024-03-3112513178core:Non-currentFinancialInstrumentscore:CostValuation2024-03-3112513178core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-03-3112513178core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-03-3112513178core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-03-3112513178core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-03-3112513178core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-03-3112513178core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-03-3112513178core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-03-3112513178core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-03-3112513178core:Non-currentFinancialInstrumentscore:CostValuation2023-03-3112513178core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-03-3112513178core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-03-3112513178core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-03-3112513178core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-03-3112513178core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-03-3112513178core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-03-3112513178core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-03-3112513178core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-03-3112513178bus:Director12023-04-012024-03-3112513178bus:Director22023-04-012024-03-31125131781bus:Director12023-04-01125131781bus:Director12023-04-012024-03-31125131781bus:Director12024-03-31125131782bus:Director22023-04-01125131782bus:Director22023-04-012024-03-31125131782bus:Director22024-03-31125131782023-04-01125131782023-04-012024-03-31125131782024-03-31

ASSURED HEALTH AND PROTECTION LIMITED

Registered Number
12513178
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2024

ASSURED HEALTH AND PROTECTION LIMITED
Company Information
for the year from 1 April 2023 to 31 March 2024

Directors

GRIERSON, Neamh Theresa Ann
GRIERSON, Nicola Clare

Registered Address

Parkhill Studio
Walton Road
Wetherby
LS22 5DZ

Registered Number

12513178 (England and Wales)
ASSURED HEALTH AND PROTECTION LIMITED
Balance Sheet as at
31 March 2024

Notes

2024

2023

£

£

£

£

Fixed assets
Tangible assets31,4011,032
1,4011,032
Current assets
Debtors46,0116,000
Cash at bank and on hand18,7797,924
24,79013,924
Creditors amounts falling due within one year5(24,109)(14,385)
Net current assets (liabilities)681(461)
Total assets less current liabilities2,082571
Provisions for liabilities(266)(196)
Net assets1,816375
Capital and reserves
Called up share capital22
Profit and loss account1,814373
Shareholders' funds1,816375
The financial statements were approved and authorised for issue by the Board of Directors on 28 October 2024, and are signed on its behalf by:
GRIERSON, Neamh Theresa Ann
Director
Registered Company No. 12513178
ASSURED HEALTH AND PROTECTION LIMITED
Notes to the Financial Statements
for the year ended 31 March 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Going concern
The directors have reviewed the financial position of the company and they are of the consideration that the company will continue trading as a going concern.
Revenue from sale of goods
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Employee benefits
Contributions to defined contribution plans are expensed in the period to which they relate.
Current taxation
Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax
Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:

Straight line (years)
Plant and machinery4
Office Equipment3
2.Average number of employees

20242023
Average number of employees during the year11
3.Tangible fixed assets

Total

£
Cost or valuation
At 01 April 231,952
Additions1,023
At 31 March 242,975
Depreciation and impairment
At 01 April 23920
Charge for year654
At 31 March 241,574
Net book value
At 31 March 241,401
At 31 March 231,032
4.Debtors: amounts due within one year

2024

2023

££
Other debtors11-
Prepayments and accrued income6,0006,000
Total6,0116,000
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
5.Creditors: amounts due within one year

2024

2023

££
Taxation and social security944514
Other creditors4,53112,885
Accrued liabilities and deferred income18,634986
Total24,10914,385
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
6.Directors advances, credits and guarantees

Brought forward

Amount advanced

Amount repaid

Carried forward

££££
GRIERSON, Neamh Theresa Ann(8,885)31,57726,223(3,531)
GRIERSON, Nicola Clare(4,000)4,0001,000(1,000)
(12,885)35,57727,223(4,531)